EGFR and non-small cell lung carcinoma: We previously reported that, in NSCLC patients, HGF is present mainly in cancer cells with acquired resistance to EGFR-TKIs, suggesting that HGF may be produced predominantly in resistant tumor cells via an autocrine mechanism [25].